Double Blind, Phase I, Randomized, Parallel Group Study of Hip Decompression Compared to Hip Decompression Supplemented at the Point of Care With Adipose Derived Regenerative Cells for Bilateral Pre-Collapse Femoral Head Osteonecrosis
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2018
At a glance
- Drugs ECCS 50 (Primary)
- Indications Osteonecrosis
- Focus Adverse reactions
- 21 Nov 2017 Status changed from not yet recruiting to recruiting.
- 21 Nov 2017 New trial record
- 13 Nov 2017 The U.S. FDA recently approved this trial, as reported in a Cytori Therapeutics media release.